Cargando…

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse

BACKGROUND: Toll-like receptor 3 (TLR3) plays an important role in the immune/inflammatory response in the nervous system and is a main pathological feature of Alzheimer’s disease (AD). This study investigates the role of early activation of TLR3 in the pathophysiological process of AD. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shang, Zhu, Taiyang, Ni, Wanyan, Zhou, Chao, Zhou, Hui, Lin, Li, Hu, Yuting, Sun, Xiaoyu, Han, Jingjing, Zhou, Yan, Jin, Guoliang, Zu, Jie, Shi, Hongjuan, Yang, Xingxing, Zhang, Zuohui, Hua, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933297/ https://www.ncbi.nlm.nih.gov/pubmed/36797783 http://dx.doi.org/10.1186/s13195-023-01186-w

Ejemplares similares

Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer’s disease
por: Zhou, Chao, et al.
Publicado: (2019)

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease
por: Zhou, Chao, et al.
Publicado: (2022)

Gain‐of‐function of progesterone receptor membrane component 2 ameliorates ischemic brain injury
por: Zhou, Chao, et al.
Publicado: (2023)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017)

Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice
por: Feng, Min, et al.
Publicado: (2022)

Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer’s disease-like pathologies in APP/PS1 mouse model
por: Yang, Cui-cui, et al.
Publicado: (2020)

Active compounds of herbs ameliorate impaired cognition in APP/PS1 mouse model of Alzheimer’s disease
por: Yu, WenJun, et al.
Publicado: (2019)

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012)

Ethanol exposure alters Alzheimer’s-related pathology, behavior, and metabolism in APP/PS1 mice
por: Day, Stephen M., et al.
Publicado: (2023)

Disruption of hippocampal neuronal circuit function depends upon behavioral state in the APP/PS1 mouse model of Alzheimer’s disease
por: Zhou, Heng, et al.
Publicado: (2022)

Ferulic Acid Ameliorates Alzheimer’s Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice
por: Wang, Ni-Ya, et al.
Publicado: (2021)

Tieguanyin Oolong Tea Extracts Alleviate Behavioral Abnormalities by Modulating Neuroinflammation in APP/PS1 Mouse Model of Alzheimer’s Disease
por: Kang, Hyunuk, et al.
Publicado: (2021)

Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
por: Wirths, Oliver, et al.
Publicado: (2009)

Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
por: Chacon-De-La-Rocha, Irene, et al.
Publicado: (2020)

Impact of Donepezil Supplementation on Alzheimer’s Disease-like Pathology and Gut Microbiome in APP/PS1 Mice
por: Li, Yuan, et al.
Publicado: (2023)

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
por: Webster, Scott J, et al.
Publicado: (2013)

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
por: Chen, Qingyou, et al.
Publicado: (2021)

Neuroprotective effects of resistance physical exercise on the APP/PS1 mouse model of Alzheimer’s disease
por: Campos, Henrique Correia, et al.
Publicado: (2023)

Herbal Formula Fo Shou San Attenuates Alzheimer's Disease-Related Pathologies via the Gut-Liver-Brain Axis in APP/PS1 Mouse Model of Alzheimer's Disease
por: Lu, Jia, et al.
Publicado: (2019)

A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer's Disease
por: Carrera, Iván, et al.
Publicado: (2015)

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
por: Kempf, Stefan J., et al.
Publicado: (2016)

Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model
por: Park, Tae-Shin, et al.
Publicado: (2017)

The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease
por: Tian, Yanna, et al.
Publicado: (2023)

Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation
por: Ma, Jing, et al.
Publicado: (2023)

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
por: Reale, Marcella, et al.
Publicado: (2018)

Traumatic Brain Injury Accelerates the Onset of Cognitive Dysfunction and Aggravates Alzheimer's-Like Pathology in the Hippocampus by Altering the Phenotype of Microglia in the APP/PS1 Mouse Model
por: Wu, Di, et al.
Publicado: (2021)

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Age- and sex-related differences of periodontal bone resorption, cognitive function, and immune state in APP/PS1 murine model of Alzheimer’s disease
por: Chen, Huiwen, et al.
Publicado: (2023)

Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
por: Faivre, Emilie, et al.
Publicado: (2013)

Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer's disease
por: Kim, Hye Yun, et al.
Publicado: (2014)

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease
por: Gelman, Simon, et al.
Publicado: (2017)

Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
por: Zhao, Yue, et al.
Publicado: (2020)

A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease
por: Georgevsky, Dana, et al.
Publicado: (2019)

Altered dorsal CA1 neuronal population coding in the APP/PS1 mouse model of Alzheimer’s disease
por: Chockanathan, Udaysankar, et al.
Publicado: (2020)

Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer’s Disease
por: Leparulo, Alessandro, et al.
Publicado: (2019)

Novel Botanical Therapeutic NB-02 Effectively Treats Alzheimer’s Neuropathophysiology in an APP/PS1 Mouse Model
por: Lee, Yee Fun, et al.
Publicado: (2021)

Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model
por: Estévez-Silva, Héctor M., et al.
Publicado: (2022)

Differential methylation of circRNA m6A in an APP/PS1 Alzheimer's disease mouse model
por: Zhang, Xiao, et al.
Publicado: (2023)

Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
por: Teich, Andrew F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l63vejbes618q5lck53bbjdhl2